In today’s briefing:
- SDA: SunCar reports 2024 financial and operating results which showed strong revenue and adjusted EBITDA growth. The company continues to secure multiple business agreements and partnerships.
- Nasdaq 100 (NDX INDEX) Outlook: Is The Bear Market Over or Not?
- JAKK: 1Q Review: Impressive Q; Remain Cautious; Reiterate Buy, $40 PT
- ABEO: Zevaskyn Approved by FDA Raising Valuation to 11
- Southern Energy Corp. (SOUC LN/SOU CN): Reserves resilient to low US gas prices
- GMGI’s goal is to maintain sufficient liquidity and financial flexibility to fund operations and growth.
- Don’t Expect A Resolution of Tariff Chaos To Lift Container Shipping Rates Like Covid-19 Did
SDA: SunCar reports 2024 financial and operating results which showed strong revenue and adjusted EBITDA growth. The company continues to secure multiple business agreements and partnerships.
- SunCar Technology Group ((NASDAQ: SDA) is a leading Chinese cloud-based provider of digital enterprise auto services and auto eInsurance services in China.
- The company offers one-stop, fully digital, on-demand automotive service systems to help enterprise clients build up their customer base and serve their end customers (auto owners).
- The company has grown revenues rapidly in recent years, which we expect to continue in the near-to-midterm.
Nasdaq 100 (NDX INDEX) Outlook: Is The Bear Market Over or Not?
- The Nasdaq-100 Stock Index (NDX INDEX) stalled this week. The week is not over yet, but let’s take a closer look at our tactical model to assess short-term scenarios.
- Obviously tariffs will impact the economy but often markets can defy rationality, leading to short-term pain if we’re positioned incorrectly.
- This insight evaluates how far the rally could extend and how deep a pullback might go, this can be of interest to option desks or to anyone looking to hedge.
JAKK: 1Q Review: Impressive Q; Remain Cautious; Reiterate Buy, $40 PT
- We are reiterating our Buy rating and $40 price target on JAKKS Pacific after the company demonstrated the overall strength of their business model and management’s ability to “control what they can control” with a highly impressive 1Q25.
- That said, we are reducing our 2025 and 2026 projections to reflect the near-term material uncertainty from the imposition of over 100% tariffs on China goods from April onward.
- While we believe JAKKS is well positioned, with strong trade, licensee and retailer relationships, a focus on lower priced goods, the ability to shift some production from China and to increase the level of international revenue, to weather the current storm and drive potential upside, we believe the current level of uncertainty will be a drag, which will begin to abate in 4Q25 and into 2026.
ABEO: Zevaskyn Approved by FDA Raising Valuation to 11
- On April 29, 2025, Abeona Therapeutics, Inc. (ABEO) announced that the U.S. Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB).
- The company announced that the wholesale acquisition cost of Zevaskyn will be $3.1 million, which is significantly higher than what we had been modeling ($1.2 million).
- Management also guided that following the commercial launch in the third quarter of 2025, the company expects 10-14 patients to be treated and revenue from those treatments to be recognized by the end of this year.
Southern Energy Corp. (SOUC LN/SOU CN): Reserves resilient to low US gas prices
- • Southern achieved production of 2,259 boe/d in 4Q24, close to with our forecasts of 2,192 boe/d.
- The YE24 working capital deficit of US$24.9 mm also met our expectations.
- • YE24 1P and 2P reserves were estimated at 12.7 mmboe and 27.9 mmboe, respectively.
GMGI’s goal is to maintain sufficient liquidity and financial flexibility to fund operations and growth.
- GMGI’s goal is to maintain sufficient liquidity and financial flexibility to fund operations and growth.
- Its capital allocation strategy also includes share repurchases and strategic M&A funded using cash, shares & earnouts.
- With strong momentum as illustrated by 63% y/y 2024 revenue improvement, GMGI is expanding its reach and portfolio.
Don’t Expect A Resolution of Tariff Chaos To Lift Container Shipping Rates Like Covid-19 Did
- The resilience of global container shipping stocks is surprising given weak price trend
- Many market participants appear to be betting on a surge in rates after tariff issues settle
- But there are several reasons why a bump in rates is unlikely in the near- to medium-term
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
